Skip to main content
. 2010 Apr 20;53(9):3748–3755. doi: 10.1021/jm100240h

Figure 3.

Figure 3

Functional assay based on measuring the production of cAMP for 3 (control), a potent A2A AR agonist, with or without 10 μM 9 or 11. The dose−response curve is shifted for both compounds, as expected in the case of competitive antagonistic inhibition. The % activation refers to production of cAMP normalized to the effect of 3 at 100 μM.